P2RX6 — Purinergic Receptor P2X Ligand-Gated Ion Channel 6
📖 Wiki Page
gene1052 wordssynced 2026-04-02
P2RX6 — Purinergic Receptor P2X Ligand-Gated Ion Channel 6
Introduction
P2RX6 encodes the P2X receptor subunit 6, a ligand-gated ion channel that responds to extracellular ATP. While less studied than other P2X subunits, P2RX6 is expressed in various tissues and plays important roles in immune function, neuromuscular signaling, and potentially in neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene"> | Field | Value | |-------|-------| | Gene Symbol | P2RX6 | | Full Name | Purinergic Receptor P2X Ligand-Gated Ion Channel 6 | | Chromosomal Location | 22q13.1 | | NCBI Gene ID | 63826 | | OMIM ID | 607184 | | Ensembl ID | ENSG00000099901 | | UniProt ID | Q9R9E9 | | Protein Family | P2X Receptor Family | | Molecular Weight | ~56 kDa | | Associated Diseases | Cancer, Immune Disorders, Alzheimer's Disease, ALS | </div>
Overview
P2RX6 encodes the P2X receptor subunit 6, a member of the P2X ligand-gated ion channel family that responds to extracellular adenosine triphosphate (ATP). Unlike many other P2X subunits that form homomeric channels, P2RX6 typically forms heteromeric channels with other P2X subunits such as P2RX4. The receptor is expressed in various tissues including immune cells, skeletal muscle, and the central nervous system [@north2002][@khakh2001].
...
P2RX6 — Purinergic Receptor P2X Ligand-Gated Ion Channel 6
Introduction
P2RX6 encodes the P2X receptor subunit 6, a ligand-gated ion channel that responds to extracellular ATP. While less studied than other P2X subunits, P2RX6 is expressed in various tissues and plays important roles in immune function, neuromuscular signaling, and potentially in neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene"> | Field | Value | |-------|-------| | Gene Symbol | P2RX6 | | Full Name | Purinergic Receptor P2X Ligand-Gated Ion Channel 6 | | Chromosomal Location | 22q13.1 | | NCBI Gene ID | 63826 | | OMIM ID | 607184 | | Ensembl ID | ENSG00000099901 | | UniProt ID | Q9R9E9 | | Protein Family | P2X Receptor Family | | Molecular Weight | ~56 kDa | | Associated Diseases | Cancer, Immune Disorders, Alzheimer's Disease, ALS | </div>
Overview
P2RX6 encodes the P2X receptor subunit 6, a member of the P2X ligand-gated ion channel family that responds to extracellular adenosine triphosphate (ATP). Unlike many other P2X subunits that form homomeric channels, P2RX6 typically forms heteromeric channels with other P2X subunits such as P2RX4. The receptor is expressed in various tissues including immune cells, skeletal muscle, and the central nervous system [@north2002][@khakh2001].
P2X receptors are a family of ATP-gated cation channels that mediate fast synaptic transmission and play roles in neuromuscular signaling, immune modulation, and sensory transduction. P2RX6, while less characterized than P2RX2, P2RX3, or P2RX7, has unique pharmacological properties and may serve specialized functions in certain cell types [@bo2003].
Structure
P2RX6 has the typical structure of P2X receptor subunits:
N-terminal extracellular domain: Contains ATP binding sites
Two transmembrane domains: Form the channel pore
C-terminal intracellular domain: Involved in regulation and trafficking
Key Structural Features
ATP binding pocket: Located in the extracellular loop
Conserved cysteine residues: Form disulfide bridges for stability
Glycosylation sites: Affect trafficking and function
Phosphorylation sites: Modulate channel activity
Channel Assembly
P2RX6 subunits can form:
Homomeric channels: Though less efficient than heteromeric
Heteromeric channels: With P2RX4, P2RX2 subunits
Functional properties: Unique pharmacology compared to other P2X receptors
Normal Function
ATP-Gated Ion Channel Activity
P2RX6 functions as an ATP-gated cation channel:
Ion selectivity: Permeable to Na⁺, K⁺, and Ca²⁺
Activation: Extracellular ATP binds to the extracellular domain
Desensitization: Varies depending on subunit composition
Current properties: Distinct from other P2X subunits
Allosteric modulators: Target specific subunit combinations
Potential Therapies
| Approach | Status | Application | |----------|--------|--------------| | P2X6 antagonists | Preclinical | Neuroinflammation | | Gene therapy | Investigational | neuromuscular disorders | | Small molecule modulators | Research phase | Various CNS disorders |
Research Directions
Elucidating physiological roles: Understanding P2RX6 function in various tissues
Disease mechanisms: Defining role in neurodegenerative diseases
Drug development: Targeting P2RX6 for therapeutic benefit
Biomarker potential: P2RX6 as disease biomarker
Key Publications
North RA. (2002). Molecular physiology of P2X receptors. Physiol Rev. PMID: 12017335(https://pubmed.ncbi.nlm.nih.gov/12017335/)
Khakh BS, et al. (2001). International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors. Pharmacol Rev. PMID: 11707441(https://pubmed.ncbi.nlm.nih.gov/11707441/)
Bo X, et al. (2003). Pharmacological properties of the homomeric P2X6 receptor. Neuropharmacology. PMID: 12657354(https://pubmed.ncbi.nlm.nih.gov/12657354/)
Xiang Z, et al. (2006). Changes in the expression of P2X receptor in Alzheimer's disease brain. J Neural Transm. PMID: 16479438(https://pubmed.ncbi.nlm.nih.gov/16479438/)
Burnstock G. (2006). Purinergic signalling—an overview. Pharmaceut Res. PMID: 16741662(https://pubmed.ncbi.nlm.nih.gov/16741662/)
The study of P2Rx6 — Purinergic Receptor P2X Ligand Gated Ion Channel 6 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.